You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

 

Online download statistics by month:

Online download statistics by month: February 2016 to August 2023

AbstractFullPdf
Feb 20161092981
Mar 20161834895
Apr 20161432855
May 20161082542
Jun 20161403048
Jul 2016621912
Aug 2016721730
Sep 2016511113
Oct 2016481321
Nov 2016661622
Dec 2016542521
Jan 2017171540
Feb 20175227
Mar 201731818
Apr 201714420
May 201764133
Jun 2017163810
Jul 2017403815
Aug 201724245
Sep 201738346
Oct 2017302815
Nov 201730268
Dec 2017292311
Jan 201825259
Feb 201823159
Mar 201848459
Apr 201838294
May 201831298
Jun 201833317
Jul 2018363613
Aug 2018292915
Sep 201822229
Oct 201824208
Nov 201826269
Dec 201816147
Jan 201918187
Feb 201915155
Mar 201913149
Apr 2019131013
May 2019171717
Jun 201919197
Jul 2019141515
Aug 201920209
Sep 201912125
Oct 2019201914
Nov 2019141311
Dec 201913133
Jan 202015145
Feb 202013136
Mar 202011119
Apr 202010103
May 202015159
Jun 2020161211
Jul 202017164
Aug 202034323
Sep 202027245
Oct 202016155
Nov 202021224
Dec 202025257
Jan 202122206
Feb 2021883
Mar 202121139
Apr 202116143
May 2021252413
Jun 202124243
Jul 202124258
Aug 2021303011
Sep 2021282810
Oct 2021161616
Nov 2021449
Dec 202113133
Jan 2022883
Feb 202211135
Mar 202213136
Apr 202218165
May 202231329
Jun 202225277
Jul 202211124
Aug 202228284
Sep 2022212113
Oct 202225266
Nov 202216149
Dec 202213132
Jan 2023151713
Feb 20231083
Mar 2023101121
Apr 2023141212
May 20237812
Jun 202314143
Jul 2023212112
Aug 202315156
Total259118551190